cagrilintide semaglutide combination weight loss trial Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for in early trials. The potential benefit Safety, tolerability, pharmacokinetics, and pharmacodynamics

Keep a dose log

References: Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation Terminal Signal: Anti-Inflammatory Effects of -Melanocyte-Stimulating Hormone Related Peptides Beyond the Pharmacophore Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system Role of vasoactive intestinal peptide in osteoarthritis vasoactive intestinal peptide Vasoactive intestinal peptide: cardiovascular effects Delta sleep-inducing peptide (DSIP): a still unresolved riddle Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes

Yang J, Tong Q, Zhang Y, Yuan S, Gao Y, Deng K, Wang Y, Lu J, Xie X, Zhang Z (2021) Overexpression of nicotinamide N -methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA

One study found that when people with mild cognitive issues and low levels of B12 were given B12 vitamins, most of them showed improved cognitive symptoms